Company Filing History:
Years Active: 2013
Title: Innovator Spotlight: Hyun-Jung Jung and Her Contributions to Biocatalysis
Introduction: Hyun-Jung Jung, located in Hwaseong-si, South Korea, is an inventive force in the field of biocatalysis. With one patent to her name, she has made significant strides in the production of vital compounds such as calcitriol and calcifediol, which are important in various medical applications.
Latest Patents: Hyun-Jung Jung's notable patent, titled "Buffer composition for catalyzing the preparation of calcitriol or calcifediol and method for preparing calcitriol or calcifediol using same," focuses on an innovative buffer composition aimed at enhancing the production efficiency of calcitriol and calcifediol. This invention describes a novel buffer that includes a metallic compound, an organic solvent, cyclodextrin, tris(hydroxymethyl)aminomethane, sodium succinate, sodium chloride, magnesium chloride, and water. The method presented in this patent asserts a high yield of the desired compounds through a bioconversion process in an enzyme reaction system, eliminating the need for sterile conditions typical of traditional microorganism cultures. This advancement not only simplifies the separation and purification process but also improves the overall quality and reduces associated costs.
Career Highlights: Hyun-Jung Jung's career is marked by her dedication to research and innovation at Ildong Pharm Co., Ltd. Her work demonstrates a clear commitment to enhancing pharmaceutical production methods through scientific research and development.
Collaborations: In her journey, she has collaborated with esteemed coworkers such as Dae-Jung Kang and Jong-Hyuk Im. Together, they have contributed to the rapid advancement of biomanufacturing techniques, employing their collective expertise to push the boundaries of medicinal chemistry.
Conclusion: With her innovative approach to the production of calcitriol and calcifediol, Hyun-Jung Jung stands as a prominent inventor in her field. Her contributions to biocatalysis continue to have a significant impact on pharmaceutical practices, showcasing the importance of innovation in driving advancements within the industry.